Universitätsspital Zürich
Zurich, Switzerland
Location status: Recruiting
NCT Number: NCT07502391
Postoperative delirium is a common and serious complication after surgery, affecting 10-40% of older patients undergoing non-cardiac procedures. It is characterized by sudden changes in attention, awareness, and thinking that fluctuate throughout the day. Delirium is associated with longer hospital stays, higher mortality, worse long-term brain function, and substantially increased healthcare costs. While several risk factors are known, it remains unclear whether a patient's sex independently influences the risk of developing postoperative delirium, as existing studies have produced conflicting results and were often not designed to specifically examine sex differences.Family visitation is a promising non-drug approach to preventing delirium. Studies in intensive care patients have shown that those who receive family visits have a significantly lower risk of developing delirium. However, it is unknown whether men and women receive different amounts of family visits after surgery, and whether any such difference could help explain sex-based disparities in delirium risk. Given that traditional gender roles in caregiving persist, women - who often serve as primary caregivers in their families - may receive fewer visits when they themselves become patients.This prospective observational study led by the University of Zurich will enroll 471 patients aged 65 years or older undergoing non-cardiac surgery lasting at least 2 hours under general or spinal anesthesia. The primary aim is to determine whether female patients have a higher risk of developing postoperative delirium within three days after surgery compared to male patients. Delirium will be assessed twice daily using the 4 A's Test (4AT), a validated and standardized screening tool. The secondary aim is to evaluate whether female patients receive fewer family visits than male patients and whether any difference in visitation mediates the sex-dependent delirium risk. Family visits will be recorded using an anonymous sign-in sheet placed in the patient's room. The study does not involve any experimental interventions; all patients receive standard clinical care. Participation is voluntary, and withdrawal is possible at any time without affecting medical treatment.
Interested in participating?
Request Info65 year and older
All sexes
Observational
Zurich, Switzerland
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Starting on postoperative day (POD) 1 and continuing until POD 3, or discharge - whichever comes first.
The primary outcome is presence of delirium as assessed by the 4AT test. A 4AT score of 4 or above will be used for dichotomous assessment of the primary outcome presence of delirium. Participants will be assessed daily in the morning and the evening.
Time frame: Starting on postoperative day (POD) 1 and continuing until POD 3, or discharge - whichever comes first
The secondary outcome is hours spend being visited. Visits shall be self-reported by the visiting party. All visits regardless of relation to the participant (e.g., family, friends, or colleagues) shall be reported. Visits should be recorded in hourly intervals, regardless of the number of visitors present (e.g., two visitors for one hour, or one visitor for one hour, should counted as the same).
Julian Rössler
Other
Sex-Dependent Risk of Postoperative Delirium and Mediating Effects of Family Visits: A Prospective Observational Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07627906
Cognition Disorders, Cognitive Dysfunction
Cairo, Cairo Governorate, Egypt
View Trial DetailsNCT06788743
Confusion, Delirium
Xi’an, Shanxi, China
View Trial DetailsNCT07314762
Confusion, Delirium
Wenzhou, Zhejiang, China
View Trial DetailsNCT07357480
Burst Suppression, Confusion
Istanbul, Bakırköy, Turkey (Türkiye)
View Trial Details